OR WAIT null SECS
© 2023 MJH Life Sciences and Consultant Live. All rights reserved.
The HCPLive influenza page is a resource for medical news and expert insights on the flu. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for influenza, and more.
December 19, 2022
New surveillance data from the 2021-22 influenza show the impact of coinfection among younger patients.
September 27, 2022
A discussion was held regarding research on the use of antivirals on younger influenza patients.
September 19, 2022
Research upholds prior recommendations for treating younger patients hospitalized with influenza.
August 11, 2022
The newest indications for the novel oral antiviral drug will make it available as an acute treatment and prophylaxis for children this flu season.
July 15, 2022
Analysis of patient-reported outcomes last flu season show an approximate 10% increased risk of mild vaccination reactions when receiving both a COVID-19 booster and flu shot instead of a lone booster dose.
April 20, 2022
The company reported interim results at a meeting this week showing multiple formulations were tolerable and safe. Next comes a phase 2 trial.
April 03, 2022
No difference in the primary outcome was observed between those randomized to influenza vaccine compared to placebo.
March 30, 2022
Males between 50-64 who have been vaccinated without erythema were at the highest risk of GBS.
Previously, few rapid diagnostic tests have been studied in home environments, and there are currently no tests approved for at-home influenza detection by the Food and Drug Administration (FDA)
March 29, 2022
Nearly all of the doctors polled recommended the pneumococcal vaccine for patients with cardiovascular disease aged 65 years and older.